This present application relates generally to prostheses and surgical methods, and specifically to tubular prostheses, including endovascular grafts and stent-grafts, and surgical techniques for using the prostheses to maintain patency of body passages such as blood vessels, and treating aneurysms.
Endovascular prostheses are sometimes used to treat aortic aneurysms. Such treatment includes implanting a stent or stent-graft within the diseased vessel to bypass the anomaly. An aneurysm is a sac formed by the dilation of the wall of the artery. Aneurysms may be congenital, but are usually caused by disease or, occasionally, by trauma. Aortic aneurysms which commonly form between the renal arteries and the iliac arteries are referred to as abdominal aortic aneurysms (“AAAs”). Other aneurysms occur in the aorta, such as thoracic aortic aneurysms (“TAAs”) and aortic uni-iliac (“AUI”) aneurysms. A TAA may occur downstream the aortic arch, i.e., in the descending aorta. Alternatively, a TAA may occur in the aortic arch itself, where the aorta branches to supply the brachiocephalic, left carotid and subclavian arteries, or may occur in the ascending aorta.
Endo-Vascular Aneurysm Repair (EVAR) has transformed the practice of treatment of aortic aneurysms from an open surgical approach to a much less invasive surgical approach. The first step of an endovascular intervention usually requires introducing a delivery system into the vasculature of a subject. If the crossing profile, i.e., the external diameter, of the delivery system is 14 Fr or lower (3 Fr=1 millimeter), a true percutaneous approach may be used, because vascular closure devices are available for proper closure of such puncture sites. If the crossing profile at least 15-16 Fr, a vascular cut-down is usually required in advance as a preparatory step to introduction of the delivery system.
Endovascular systems for treatment of supra-renal aneurysms generally require the preparatory step of a vascular cut-down. A cut-down is the localized surgical exposure of blood vessels for accessing the subject's vasculature. For example, most surgical cut-downs used in EVAR procedures are performed in the vicinity of the pubis, exposing the iliac arteries. Surgical cut-downs have related complications and co-morbidities, including difficulty in controlling bleeding at the access site, false aneurysms, and vascular obstruction. It is therefore desirable to use a purely percutaneous approach, instead of a vascular cut-down.
Endovascular stent-grafts for treating the thoracic aorta usually require a 20-22 Fr delivery system, because of the large amount of graft material indicated by the diameter of the aorta above the level of the renal arteries (30-40 mm diameter or more in some subjects). Currently used graft materials are PET (Poly Ethylene Therephtalate) and ePTFE (expanded Poly-Tetra-Fluoro-Ethylene). The thickness and circumferential length of the graft have the most substantial effect on the crossing profile of an endovascular system. The use of thinner graft materials generally reduces long-term durability of the graft material.
In some applications of the present invention, a multi-component endovascular stent-graft system has a body portion that comprises a plurality of stent-grafts. The stent-grafts are configured to be assembled in situ in a blood vessel of a subject to define a circumferentially-complete fluid flow path. The stent-grafts comprise respective stent members, which are shaped so as to define respective circumferentially-complete tubes when the stent-grafts are in respective radially-expanded states. The stent-grafts further comprise respective graft members that are securely fixed to the stent members, respectively. The graft members circumscribe respective circumferential arcs of the respective stent members, which circumferential arcs have respective extents that are less than entire circumferences of the respective stent members at least partially along respective axial lengths of the stent members. The graft members collectively cover an entire circumference of the body portion along the entire axial length of the body portion, when (a) the stent-grafts are nested within one another along the entire axial length of the body portion, with predefined rotational and axial relationships therebetween, and (b) the stent-grafts are in their respective radially-expanded states. Typically, in order to provide good circumferential sealing between circumferentially-adjacent stent-grafts, pairs of circumferentially-adjacent graft members have respective circumferential overlaps having respective arc extents.
Because each of the stent-grafts comprises substantially less graft and stent material than a typical single-component full-circumference stent-graft, the stent-grafts typically have relatively small crossing profiles. The stent-grafts thus can typically be deployed using catheters having a diameter of no more than 14 Fr. This generally enables the use of a true percutaneous surgical technique, without the need for a vascular cut-down. In addition, because each of the stent members defines a circumferentially-complete tube (at least one point along the length of each stent-graft), upon deployment the stent-grafts are tightly coupled to one another, and form tight blood-impervious seals with one another. Furthermore, if the stent-grafts did not define circumferentially-complete tubes, the stent-grafts might have a tendency to flatten upon deployment.
For some applications, the stent-graft system is deployed in the aorta for treating an aneurysm. During an implementation procedure, a first one of the stent-grafts is transvascularly (typically percutaneously) introduced into the aorta via one of the iliac arteries, while the stent-graft is positioned in a delivery catheter, restrained in its radially-compressed state by the catheter. After being positioned at a desired location in the aorta, the first stein-graft is deployed from the catheter, and assumes its radially-expanded state. A second one of the stent-grafts, while restrained in its radially-compressed state in a catheter, is advanced through the previously-deployed first stent-graft, until the second stent-graft is positioned at least partially (typically, entirely) within the first stent-graft, generally axially aligned with the first stent-graft. Before it is deployed from delivery catheter, the second stent-graft is properly rotationally aligned with the previously-deployed first stent-graft, such that the respective graft members of the stent-grafts will together form a circumferentially-complete fluid flow guide upon full deployment of the second stent-graft (and the other remaining stent-grafts, if any). The second stent-graft is then deployed from the catheter, thereby nesting the second stent-graft within the first stent-graft. For configurations in which the stent-graft system comprises more than two stent-grafts, the procedure described above is repeated for the additional stent-grafts, until the stein-grafts are all deployed to together form the stent-graft system. As a result, the stent-graft system has been assembled in situ to form a circumferentially complete fluid flow guide comprising all of the stent-grafts.
There is therefore provided, in accordance with an application of the present invention, apparatus including a multi-component endovascular stent-graft system, which has proximal and distal ends, and a body portion disposed along at least a part of the stent-graft system longitudinally between the proximal and distal ends, which body portion has an axial length and includes a plurality of stent-grafts, which (a) are configured to assume respective radially-compressed states for transluminal delivery, and respective radially-expanded states for intraluminal fixation, and (b) include:
wherein the graft members collectively cover an entire circumference of the body portion along the entire axial length of the body portion, when (a) the stent-grafts are nested within one another along the entire axial length of the body portion, with predefined rotational and axial relationships therebetween, and (b) the stent-grafts are in their respective radially-expanded states.
For some applications, the graft members are securely fixed to the stent members, respectively, such that the circumferential arc extents are less than the entire circumferences of the respective stent members along at least 80% of the respective axial lengths of the stent members, when the stent-grafts are in their radially-expanded states. For some applications, the graft members are securely fixed to the stent members, respectively, such that the circumferential arc extents are less than the entire circumferences of the respective stent members along the entire respective axial lengths of the stent members, when the stent-grafts are in their radially-expanded states.
For some applications, the circumferential arcs have respective arc extents, at least one of which is between 1.1π (pi) and 1.4π (pi) radians. For some applications, each of the respective arc extents is between 1.1π (pi) and 1.4π (pi) radians. For some applications, the stent-graft system includes exactly two stent-grafts.
For some applications, the circumferential arcs have respective arc extents, at least one of which is between 0.75π (pi) and 1.1π (pi) radians. For some applications, each of the respective arc extents is between 0.75π (pi) and 1.1π (pi) radians. For some applications, the stent-graft system includes exactly three stent-grafts.
For some applications, the circumferential arcs have respective arc extents, at least one of which is between 0.6π (pi) and 0.75π (pi) radians. For some applications, each of the respective arc extents is between 0.67π (pi) and 0.752π (pi) radians. For some applications, the stent-graft system includes exactly four stent-grafts.
For some applications, pairs of circumferentially-adjacent graft members have respective circumferential overlaps having respective arc extents, each of which is at least 0.05π (pi) radians, when (a) the stent-grafts are nested within one another along the entire axial length of the body portion, with the predefined rotational and axial relationships therebetween, and (b) the stent-grafts are in their respective radially-expanded states. For some applications, each of the overlaps is at least 0.1π (pi) radians. For some applications, the circumferential arcs have respective arc extents, a sum of which is greater than 2.2π (pi) radians, when (a) the stent-grafts are nested within one another along the entire axial length of the body portion, with the predefined rotational and axial relationships therebetween, and (b) the stent-grafts are in their respective radially-expanded states. For some applications, the sum is equal to at least 2.6π (pi) radians. For some applications, the sum is equal at least (a) 2π (pi) plus (b) a product of (i) a number of the stent-grafts and (ii) 0.1π (pi) radians.
For any of the applications described above, the circumferential arcs may have respective arc angular centers, which are positioned at respective substantially constant circumferential locations along the entire axial length of the body portion, when (a) the stent-grafts are nested within one another along the entire axial length of the body portion, with the predefined rotational and axial relationships therebetween, and (h) the stent-grafts are in their respective radially-expanded states.
For any of the applications described above, the circumferential arcs may have respective arc angular centers, which are positioned at respective circumferential locations that vary along at least a portion of the axial length of the body portion, when (a) the stent-grafts are nested within one another along the entire axial length of the body portion, with the predefined rotational and axial relationships therebetween, and (b) the stent-grafts are in their respective radially-expanded states. For some applications, the respective circumferential locations vary along the entire axial length of the body portion when (a) the stent-grafts are nested within one another along the entire axial length of the body portion, with the predefined rotational and axial relationships therebetween, and (b) the stent-grafts are in their respective radially-expanded states. For some applications, the circumferential arcs have respective arc extents, which are generally constant along the entire axial length of the body portion, when (a) the stent-grafts are nested within one another along the entire axial length of the body portion, with the predefined rotational and axial relationships therebetween, and (b) the stent-grafts are in their respective radially-expanded states.
For any of the applications described above, the circumferential arcs may have respective arc extents, which vary along the entire axial length of the body portion, when (a) the stent-grafts are nested within one another along the entire axial length of the body portion, with the predefined rotational and axial relationships therebetween, and (b) the stent-grafts are in their respective radially-expanded states.
For any of the applications described above, the stent-graft system may be shaped so as to define a side-facing fenestration, when (a) the stent-grafts are nested within one another along the entire axial length of the body portion, with the predefined rotational and axial relationships therebetween, and (b) the stent-grafts are in their respective radially-expanded states. For some applications, the side-facing fenestration is generally circular. For some applications, a perimeter of the fenestration is between 10% and 50% of a perimeter of the stent-graft system adjacent the fenestration.
For any of the applications described above, the body portion may be disposed along only part of the stent-graft system.
For any of the applications described above, the stent members may be self-expanding.
For any of the applications described above, the stent members may include a superelastic metallic alloy. Alternatively or additionally, for any of the applications described above, the stent members may include a shape memory metallic alloy. Alternatively or additionally, for any of the applications described above, the stent members may include Nitinol.
For any of the applications described above, the stent-graft system may further include a plurality of outwardly protruding fixation elements. For some applications, the fixation elements are positioned at the proximal end of the stent-graft system. For some applications, the fixation elements include barbs.
For any of the applications described above, each of the stent-grafts may further include one or more radiopaque markers.
For any of the applications described above, each of the tubes respectively defined by the stent members may be circumferentially-complete along at least three longitudinal locations thereof.
For any of the applications described above, the apparatus may further include a plurality of delivery catheters, in which the stent-grafts are respectively initially positioned in their radially-compressed states.
There is further provided, in accordance with an application of the present invention, a method including:
wherein deploying the stent-grafts includes deploying the stent-grafts such that the graft members collectively cover an entire circumference of the body portion along the entire axial length of the body portion.
For some applications, deploying the stent-grafts includes deploying the stent-grafts such that pairs of circumferentially-adjacent graft members have respective circumferential overlaps having respective arc extents, each of which is at least 0.05π (pi) radians, such as at least 0.1π (pi) radians.
For some applications, providing the stent-graft system includes providing the stent-graft system in which each of the tubes respectively defined by the stent members is circumferentially-complete along an entire length thereof.
For some applications, the blood vessel is an aorta, and deploying the stent-grafts includes deploying the stent-grafts in the aorta.
For some applications, the method further includes identifying the subject as suffering from an aortic aneurysm, and deploying the stent-grafts includes deploying the stent-grafts responsively to the identifying.
The present invention will be more fully understood from the following detailed description of embodiments thereof, taken together with the drawings, in which:
Body portion 16 comprises a plurality of stent-grafts 20. In the exemplary configuration shown in
Stent-graft system 10 is assembled in situ by nesting stent-grafts 20 within one another, as shown in
For some applications, proximal and/or distal portions of the stent-graft system extend proximally and/or distally beyond the body portion comprise anchoring elements, for example as described hereinbelow with reference to
Each of stent-grafts 20 comprises a stent member 22 and a graft member 24. Stent member 22 comprises a plurality of structural stent elements (struts) 26, which, for some applications, are arranged as a plurality of circumferential bands 28. For some applications, at least some of, e.g., all of, the structural stent elements are interconnected, while for other applications, at least a portion of, e.g., all, of the structural stent elements are not interconnected. In the configuration shown in
Typically, stent members 22 are self-expanding. For some applications, stent members 22 comprise a superelastic metallic alloy, a shape memory metallic alloy, and/or Nitinol.
Each of graft members 24 comprises one or more biologically-compatible substantially blood-impervious flexible sheets, which are securely fixed to stent member 22, either outside or within the stent member, such as by stitching, and covers either an external or an internal surface of a portion of the stent member. The flexible sheet may comprise, for example, a polymeric film material (e.g., polytetrafluoroethylene), a polymeric textile material (e.g., woven polyethylene terephthalate (PET)), natural tissue graft (e.g., saphenous vein or collagen), or a combination thereof.
Reference is still made to
As shown in
Typically, graft members 24 are securely fixed to stent members 22, respectively, such that the circumferential arc extents are less than the entire circumferences of the respective stent members along at least 80% of the respective axial lengths of stent members 22, such as along at least 90%, or the entire respective axial lengths, of the stent members, when the stent-grafts are in their radially-expanded states. As a result, when the graft members are radially-compressed for delivery, the crossing profiles of the graft members are less than they would be if the graft members extended around the entire circumferences of the stent members.
For some applications, such as in which stent-graft system 10 comprises exactly two stent-grafts 20, circumferential arcs 40 have respective arc extents, at least one of which is between 1.1π (pi) and 1.4π (pi) radians. Optionally, each (i.e., all) of the respective arc extents is between 1.1π (pi) and 1.4π (pi) radians. For some applications, such as in which stent-graft system 10 comprises exactly three stent-grafts 20, circumferential arcs 40 have respective arc extents, at least one of which is between 0.75π (pi) and 1.1π (pi) radians. Optionally, each (i.e., all) of the respective arc extents is between 0.75π (pi) and 1.1π (pi) radians. For some applications, such as in which stent-graft system 10 comprises exactly four stent-grafts 20, circumferential arcs 40 have respective arc extents, at least one of which is between 0.6π (pi) and 0.75π (pi) radians. Optionally, each (i.e., all) of the respective arc extents is between 0.6π (pi) and 0.75π (pi) radians.
Typically, in order to provide good circumferential sealing between circumferentially-adjacent stent-grafts 20, pairs of circumferentially-adjacent graft members 22 have respective circumferential overlaps 42 having respective arc extents, when (a) stent-grafts 20 are nested within one another along entire axial length L of body portion 16, with the predefined rotational and axial relationships therebetween, and (b) stent-grafts 20 are in their respective radially-expanded states. Typically, each of the arc extents is at least 0.05π (pi) radians, such as at least 0.1π (pi) radians.
For some applications, circumferential arcs 40 have respective arc extents, a sum of which is greater than 2.2π (pi) radians, such as at least 2.6π (pi) radians, when (a) stent-grafts 20 are nested within one another along entire axial length L of the body portion 16, with the predefined rotational and axial relationships therebetween, and (b) stent-grafts 20 are in their respective radially-expanded states. Optionally, the sum is equal at least (a) 2π (pi) plus (b) a product of (i) a number of stent-grafts 20 and (ii) 0.1π (pi) radians.
For some applications, such as shown in
Alternatively or additionally, for some applications, circumferential arcs 40 have respective arc extents, which are generally constant along entire axial length L of the body portion 16, when (a) stent-grafts 20 are nested within one another along entire axial length L of body portion 16, with the predefined rotational and axial relationships therebetween, and (b) stent-grafts 20 are in their respective radially-expanded states. Alternatively, the arc extents vary along at least a portion (e.g., the entire) axial length L of body portion 16.
Reference is now made to
Alternatively or additionally, for some applications, circumferential arcs 40 have respective arc extents, which are generally constant along entire axial length L of the body portion 16, when (a) stent-grafts 20 are nested within one another along entire axial length L of body portion 16, with the predefined rotational and axial relationships therebetween, and (b) stent-grafts 20 are in their respective radially-expanded states. Alternatively, the arc extents vary along at least a portion (e.g., the entire) axial length L of body portion 16.
Reference is now made to
As shown in
Before it is deployed from delivery catheter 72, stent-graft 20B is properly rotationally aligned with previously-deployed stent-graft 20A, such that graft members 24A and 24B (and the other remaining stent-grafts 20, if any, as described below) will together form a circumferentially-complete fluid flow guide upon full deployment of stent-graft 20B (and the other remaining stent-grafts 20, if any, as described below).
For configurations in which stent-graft system 10 comprises more than two stent-grafts 20, the procedure described above for deploying stent-grafts 20A and 20B is repeated for the additional stent-grafts, until the stent-grafts are all deployed to together form stent-graft system 10. Each of the subsequently-deployed stent-grafts is positioned at least partially within all of the already-deployed stent-grafts.
Reference is again made to
Reference is made to
Reference is made to
Stent-graft system 10 may be deployed alone, or as a component of a larger stent-graft system comprising additional stent-grafts, for example as described with reference to FIGS. 4E and/or 21B of the '208 publication, mutatis mutandis, or in PCT Publication WO 08/107885, mutatis mutandis, which is incorporated herein by reference. For some applications, stent-graft system 10 defines a single lumen, while for other applications, the stent-graft system 10 defines a plurality of lumen, e.g., is bifurcated, such as described with reference to FIG. 3 of the above-mentioned '208 publication, mutatis mutandis.
Although the endovascular stent-graft system is generally described herein as being deployed via an iliac artery and the aorto-iliac bifurcation, for some applications, the prostheses are instead deployed via a subclavian artery. Furthermore, although the endovascular stent-graft system is generally described herein as being deployed in the aorta, the system may also be deployed in another blood vessel, such as another artery, e.g., an aneurysmatic artery, such as an aneurysmatic iliac artery.
The scope of the present invention includes embodiments described in the following applications, which are assigned to the assignee of the present application and are incorporated herein by reference. In an embodiment, techniques and apparatus described in one or more of the following applications are combined with techniques and apparatus described herein:
It will be appreciated by persons skilled in the art that the present invention is not limited to what has been particularly shown and described hereinabove. Rather, the scope of the present invention includes both combinations and subcombinations of the various features described hereinabove, as well as variations and modifications thereof that are not in the prior art, which would occur to persons skilled in the art upon reading the foregoing description.
The present application claims priority from U.S. patent application Ser. No. 61/499,195, filed Jun. 21, 2011, which is assigned to the assignee of the present application and is incorporated herein by reference.
Filing Document | Filing Date | Country | Kind | 371c Date |
---|---|---|---|---|
PCT/IL2012/000241 | 6/19/2012 | WO | 00 | 2/8/2013 |
Publishing Document | Publishing Date | Country | Kind |
---|---|---|---|
WO2012/176187 | 12/27/2012 | WO | A |
Number | Name | Date | Kind |
---|---|---|---|
4355426 | MacGregor | Oct 1982 | A |
4505767 | Quin | Mar 1985 | A |
4562596 | Kornberg | Jan 1986 | A |
4577631 | Kreamer | Mar 1986 | A |
4617932 | Kornberg | Oct 1986 | A |
4665906 | Jervis | May 1987 | A |
4739762 | Palmaz | Apr 1988 | A |
4787899 | Lazarus | Nov 1988 | A |
4878906 | Lindemann et al. | Nov 1989 | A |
4886062 | Wiktor | Dec 1989 | A |
4938740 | Melbin | Jul 1990 | A |
4969458 | Wiktor | Nov 1990 | A |
5042707 | Taheri | Aug 1991 | A |
5064435 | Porter | Nov 1991 | A |
5104404 | Wolff | Apr 1992 | A |
5122136 | Guglielmi et al. | Jun 1992 | A |
5133732 | Wiktor | Jul 1992 | A |
5234448 | Wholey et al. | Aug 1993 | A |
5486183 | Middleman et al. | Jan 1996 | A |
5507769 | Marin et al. | Apr 1996 | A |
5509923 | Middleman et al. | Apr 1996 | A |
5522880 | Barone et al. | Jun 1996 | A |
5527322 | Klein et al. | Jun 1996 | A |
5549662 | Fordenbacher | Aug 1996 | A |
5554181 | Das | Sep 1996 | A |
5556413 | Lam | Sep 1996 | A |
5562724 | Vorwerk et al. | Oct 1996 | A |
5607445 | Summers | Mar 1997 | A |
5613974 | Andreas et al. | Mar 1997 | A |
5632746 | Middleman et al. | May 1997 | A |
5632763 | Glastra | May 1997 | A |
5632772 | Alcime et al. | May 1997 | A |
5639278 | Dereume et al. | Jun 1997 | A |
5643340 | Nunokawa | Jul 1997 | A |
5653743 | Martin | Aug 1997 | A |
5676696 | Marcade | Oct 1997 | A |
5676697 | McDonald | Oct 1997 | A |
5728134 | Barak | Mar 1998 | A |
5749879 | Middleman et al. | May 1998 | A |
5755770 | Ravenscroft | May 1998 | A |
5755771 | Penn et al. | May 1998 | A |
5755777 | Chuter | May 1998 | A |
5755781 | Jayaraman | May 1998 | A |
5769882 | Fogarty et al. | Jun 1998 | A |
5769884 | Solovay | Jun 1998 | A |
5782903 | Wiktor | Jul 1998 | A |
5782906 | Marshall et al. | Jul 1998 | A |
5824040 | Cox et al. | Oct 1998 | A |
5827321 | Roubin et al. | Oct 1998 | A |
5843170 | Ahn | Dec 1998 | A |
5855600 | Alt | Jan 1999 | A |
5860991 | Klein et al. | Jan 1999 | A |
5876432 | Lau et al. | Mar 1999 | A |
5906641 | Thompson et al. | May 1999 | A |
5921994 | Andreas et al. | Jul 1999 | A |
5980552 | Pinchasik et al. | Nov 1999 | A |
6015431 | Thornton et al. | Jan 2000 | A |
6016810 | Ravenscroft | Jan 2000 | A |
6030414 | Taheri | Feb 2000 | A |
6033435 | Penn et al. | Mar 2000 | A |
6036725 | Avellanet | Mar 2000 | A |
6059824 | Taheri | May 2000 | A |
6099497 | Adams et al. | Aug 2000 | A |
6117145 | Wood et al. | Sep 2000 | A |
6132457 | Chobotov | Oct 2000 | A |
6156064 | Chouinard | Dec 2000 | A |
6200339 | Leschinsky et al. | Mar 2001 | B1 |
6206893 | Klein et al. | Mar 2001 | B1 |
6270524 | Kim | Aug 2001 | B1 |
6283991 | Cox et al. | Sep 2001 | B1 |
6290720 | Khosravi et al. | Sep 2001 | B1 |
6312458 | Golds | Nov 2001 | B1 |
6325823 | Horzewski et al. | Dec 2001 | B1 |
6344056 | Dehdashtian | Feb 2002 | B1 |
6428565 | Wisselink | Aug 2002 | B1 |
6506211 | Skubitz et al. | Jan 2003 | B1 |
6520988 | Colombo et al. | Feb 2003 | B1 |
6613078 | Barone | Sep 2003 | B1 |
6635083 | Cheng et al. | Oct 2003 | B1 |
6652567 | Deaton | Nov 2003 | B1 |
6656214 | Fogarty et al. | Dec 2003 | B1 |
6692520 | Gambale et al. | Feb 2004 | B1 |
6695833 | Frantzen | Feb 2004 | B1 |
6743195 | Zucker | Jun 2004 | B2 |
6752826 | Holloway et al. | Jun 2004 | B2 |
6776794 | Hong et al. | Aug 2004 | B1 |
6808534 | Escano | Oct 2004 | B1 |
6814749 | Cox et al. | Nov 2004 | B2 |
6814752 | Chuter | Nov 2004 | B1 |
6824560 | Pelton | Nov 2004 | B2 |
6846321 | Zucker | Jan 2005 | B2 |
6907285 | Denker et al. | Jun 2005 | B2 |
6908477 | McGuckin, Jr. et al. | Jun 2005 | B2 |
6929660 | Ainsworth et al. | Aug 2005 | B1 |
6942691 | Chuter | Sep 2005 | B1 |
6964679 | Marcade et al. | Nov 2005 | B1 |
6986774 | Middleman et al. | Jan 2006 | B2 |
7008441 | Zucker | Mar 2006 | B2 |
7044962 | Elliott | May 2006 | B2 |
7105020 | Greenberg et al. | Sep 2006 | B2 |
7112217 | Kugler et al. | Sep 2006 | B1 |
7115127 | Lindenbaum et al. | Oct 2006 | B2 |
7144421 | Carpenter et al. | Dec 2006 | B2 |
7198638 | Dong | Apr 2007 | B2 |
7201772 | Schwammenthal | Apr 2007 | B2 |
7223266 | Lindenbaum et al. | May 2007 | B2 |
7279003 | Berra et al. | Oct 2007 | B2 |
7294145 | Ward | Nov 2007 | B2 |
7306623 | Watson | Dec 2007 | B2 |
7341598 | Davidson et al. | Mar 2008 | B2 |
7407509 | Greenberg et al. | Aug 2008 | B2 |
7429269 | Schwammenthal | Sep 2008 | B2 |
7438721 | Doig | Oct 2008 | B2 |
7442204 | Schwammenthal | Oct 2008 | B2 |
7473272 | Pryor | Jan 2009 | B2 |
7491231 | Nazzaro | Feb 2009 | B2 |
7537609 | Davidson et al. | May 2009 | B2 |
7540881 | Meyer et al. | Jun 2009 | B2 |
7544160 | Gross | Jun 2009 | B2 |
7637939 | Tischler | Dec 2009 | B2 |
7662161 | Briganti et al. | Feb 2010 | B2 |
7662168 | McGuckin, Jr. et al. | Feb 2010 | B2 |
7678141 | Greenan et al. | Mar 2010 | B2 |
7722626 | Middleman et al. | May 2010 | B2 |
7731732 | Ken | Jun 2010 | B2 |
7803178 | Whirley et al. | Sep 2010 | B2 |
7806923 | Moloney | Oct 2010 | B2 |
7815673 | Bloom et al. | Oct 2010 | B2 |
7887575 | Kujawski | Feb 2011 | B2 |
7955374 | Erickson et al. | Jun 2011 | B2 |
7959662 | Erbel et al. | Jun 2011 | B2 |
8066755 | Zacharias et al. | Nov 2011 | B2 |
8080053 | Satasiya et al. | Dec 2011 | B2 |
8172892 | Chuter et al. | May 2012 | B2 |
20010004705 | Killion et al. | Jun 2001 | A1 |
20010014823 | Resseman et al. | Aug 2001 | A1 |
20010034550 | Buirge et al. | Oct 2001 | A1 |
20010044651 | Steinke et al. | Nov 2001 | A1 |
20010044652 | Moore | Nov 2001 | A1 |
20010047198 | Drasler et al. | Nov 2001 | A1 |
20010053930 | Kugler et al. | Dec 2001 | A1 |
20020040236 | Lau et al. | Apr 2002 | A1 |
20020099438 | Furst | Jul 2002 | A1 |
20020099441 | Dehdashtian | Jul 2002 | A1 |
20020107564 | Cox et al. | Aug 2002 | A1 |
20020123791 | Harrison | Sep 2002 | A1 |
20020156495 | Brenneman et al. | Oct 2002 | A1 |
20030040791 | Oktay | Feb 2003 | A1 |
20030074055 | Haverkost | Apr 2003 | A1 |
20030093145 | Lawrence-Brown et al. | May 2003 | A1 |
20030130720 | DePalma et al. | Jul 2003 | A1 |
20030144725 | Lombardi | Jul 2003 | A1 |
20030153968 | Geis et al. | Aug 2003 | A1 |
20030191523 | Hojeibane | Oct 2003 | A1 |
20030199967 | Hartley et al. | Oct 2003 | A1 |
20030199968 | Ainsworth et al. | Oct 2003 | A1 |
20030212449 | Cox | Nov 2003 | A1 |
20030236567 | Elliot | Dec 2003 | A1 |
20040015227 | Vardi et al. | Jan 2004 | A1 |
20040015229 | Fulkerson et al. | Jan 2004 | A1 |
20040098091 | Erbel et al. | May 2004 | A1 |
20040106972 | Deaton | Jun 2004 | A1 |
20040106978 | Greenberg et al. | Jun 2004 | A1 |
20040133266 | Clerc et al. | Jul 2004 | A1 |
20040171978 | Shalaby | Sep 2004 | A1 |
20040181149 | Langlotz et al. | Sep 2004 | A1 |
20040215327 | Doig et al. | Oct 2004 | A1 |
20050033406 | Barnhart et al. | Feb 2005 | A1 |
20050049678 | Cocks et al. | Mar 2005 | A1 |
20050065545 | Wallace | Mar 2005 | A1 |
20050085900 | Case et al. | Apr 2005 | A1 |
20050102018 | Carpenter et al. | May 2005 | A1 |
20050102021 | Osborne | May 2005 | A1 |
20050131517 | Hartley et al. | Jun 2005 | A1 |
20050149166 | Schaeffer et al. | Jul 2005 | A1 |
20050154448 | Cully et al. | Jul 2005 | A1 |
20050171598 | Schaeffer | Aug 2005 | A1 |
20050203606 | VanCamp | Sep 2005 | A1 |
20050222667 | Hunt | Oct 2005 | A1 |
20050222668 | Schaeffer et al. | Oct 2005 | A1 |
20050222669 | Purdy | Oct 2005 | A1 |
20050266042 | Tseng | Dec 2005 | A1 |
20050283188 | Loshakove et al. | Dec 2005 | A1 |
20060015170 | Jones et al. | Jan 2006 | A1 |
20060052799 | Middleman et al. | Mar 2006 | A1 |
20060069426 | Weinberger | Mar 2006 | A1 |
20060100684 | Elliott | May 2006 | A1 |
20060106406 | Weinberger | May 2006 | A1 |
20060149360 | Schwammenthal | Jul 2006 | A1 |
20060155358 | LaDuca et al. | Jul 2006 | A1 |
20060155366 | LaDuca et al. | Jul 2006 | A1 |
20060167476 | Burdulis, Jr. et al. | Jul 2006 | A1 |
20060173530 | Das | Aug 2006 | A1 |
20060193892 | Furst et al. | Aug 2006 | A1 |
20060229709 | Morris et al. | Oct 2006 | A1 |
20060241740 | Vardi et al. | Oct 2006 | A1 |
20060281966 | Peacock, III | Dec 2006 | A1 |
20070021822 | Boatman | Jan 2007 | A1 |
20070043425 | Hartley et al. | Feb 2007 | A1 |
20070050011 | Klein et al. | Mar 2007 | A1 |
20070055350 | Erickson et al. | Mar 2007 | A1 |
20070055358 | Krolik et al. | Mar 2007 | A1 |
20070060989 | Deem et al. | Mar 2007 | A1 |
20070061002 | Paul, Jr. et al. | Mar 2007 | A1 |
20070073373 | Bonsignore | Mar 2007 | A1 |
20070088425 | Schaeffer | Apr 2007 | A1 |
20070112344 | Keilman | May 2007 | A1 |
20070135677 | Miller et al. | Jun 2007 | A1 |
20070142896 | Anderson et al. | Jun 2007 | A1 |
20070150051 | Menardiere et al. | Jun 2007 | A1 |
20070156167 | Connors et al. | Jul 2007 | A1 |
20070167898 | Peters et al. | Jul 2007 | A1 |
20070167955 | Menardiere et al. | Jul 2007 | A1 |
20070168018 | Amplatz et al. | Jul 2007 | A1 |
20070179598 | Duerig | Aug 2007 | A1 |
20070185565 | Schwammenthal et al. | Aug 2007 | A1 |
20070208410 | Berra et al. | Sep 2007 | A1 |
20070213805 | Schaeffer et al. | Sep 2007 | A1 |
20070213807 | Roubin et al. | Sep 2007 | A1 |
20070219610 | Israel | Sep 2007 | A1 |
20070219627 | Chu | Sep 2007 | A1 |
20070233229 | Berra et al. | Oct 2007 | A1 |
20070237973 | Purdy et al. | Oct 2007 | A1 |
20070244542 | Greenan et al. | Oct 2007 | A1 |
20070244543 | Mitchell | Oct 2007 | A1 |
20070244547 | Greenan | Oct 2007 | A1 |
20070250154 | Greenberg et al. | Oct 2007 | A1 |
20070255388 | Rudakov et al. | Nov 2007 | A1 |
20080002871 | Gunzert-Marx et al. | Jan 2008 | A1 |
20080015673 | Chuter | Jan 2008 | A1 |
20080058918 | Watson | Mar 2008 | A1 |
20080097578 | Erickson et al. | Apr 2008 | A1 |
20080109066 | Quinn | May 2008 | A1 |
20080114444 | Yu | May 2008 | A1 |
20080114445 | Melsheimer et al. | May 2008 | A1 |
20080147173 | McIff et al. | Jun 2008 | A1 |
20080167704 | Wright et al. | Jul 2008 | A1 |
20080195190 | Bland et al. | Aug 2008 | A1 |
20080195191 | Luo et al. | Aug 2008 | A1 |
20080215134 | Lawrence/Brown | Sep 2008 | A1 |
20080249598 | Sherry | Oct 2008 | A1 |
20080269789 | Eli | Oct 2008 | A1 |
20080275540 | Wen | Nov 2008 | A1 |
20080275542 | LaDuca et al. | Nov 2008 | A1 |
20080288044 | Osborne | Nov 2008 | A1 |
20080300665 | Lootz et al. | Dec 2008 | A1 |
20080319528 | Yribarren et al. | Dec 2008 | A1 |
20090012597 | Doig et al. | Jan 2009 | A1 |
20090012602 | Quadri | Jan 2009 | A1 |
20090030502 | Sun et al. | Jan 2009 | A1 |
20090048663 | Greenberg | Feb 2009 | A1 |
20090054967 | Das | Feb 2009 | A1 |
20090062899 | Dang et al. | Mar 2009 | A1 |
20090069882 | Venturelli et al. | Mar 2009 | A1 |
20090082841 | Zacharias et al. | Mar 2009 | A1 |
20090099648 | Yu | Apr 2009 | A1 |
20090099649 | Chobotov et al. | Apr 2009 | A1 |
20090099650 | Bolduc et al. | Apr 2009 | A1 |
20090105809 | Lee et al. | Apr 2009 | A1 |
20090112233 | Xiao | Apr 2009 | A1 |
20090125096 | Chu et al. | May 2009 | A1 |
20090138067 | Pinchuk et al. | May 2009 | A1 |
20090149877 | Hanson et al. | Jun 2009 | A1 |
20090227997 | Wang et al. | Sep 2009 | A1 |
20090240316 | Bruszewski | Sep 2009 | A1 |
20090248134 | Dierking et al. | Oct 2009 | A1 |
20090254170 | Hartley et al. | Oct 2009 | A1 |
20090259290 | Bruszewski et al. | Oct 2009 | A1 |
20090287145 | Cragg et al. | Nov 2009 | A1 |
20100004728 | Rao et al. | Jan 2010 | A1 |
20100029608 | Finley et al. | Feb 2010 | A1 |
20100063575 | Shalev | Mar 2010 | A1 |
20100070019 | Shalev | Mar 2010 | A1 |
20100082091 | Berez et al. | Apr 2010 | A1 |
20100161026 | Brocker et al. | Jun 2010 | A1 |
20100211159 | Schmid et al. | Aug 2010 | A1 |
20100256725 | Rasmussen | Oct 2010 | A1 |
20100292774 | Shalev | Nov 2010 | A1 |
20100318171 | Porter et al. | Dec 2010 | A1 |
20110093002 | Rucker et al. | Apr 2011 | A1 |
20110125251 | Cottone et al. | May 2011 | A1 |
20110208289 | Shalev | Aug 2011 | A1 |
20110208296 | Duffy et al. | Aug 2011 | A1 |
20110208297 | Tuval | Aug 2011 | A1 |
20110208298 | Tuval | Aug 2011 | A1 |
20110218607 | Arbefeuille et al. | Sep 2011 | A1 |
20110264184 | Heltai | Oct 2011 | A1 |
20120310324 | Benary et al. | Dec 2012 | A1 |
Number | Date | Country |
---|---|---|
2 497 704 | Mar 2004 | CA |
201058061 | May 2008 | CN |
1177780 | Feb 2002 | EP |
1325716 | Jul 2003 | EP |
2 298 248 | Mar 2011 | EP |
2002-253682 | Sep 2002 | JP |
2004017868 | Mar 2004 | WO |
2005002466 | Jan 2005 | WO |
2005037138 | Apr 2005 | WO |
2005041781 | May 2005 | WO |
2005041783 | May 2005 | WO |
2006007389 | Jan 2006 | WO |
2006028925 | Mar 2006 | WO |
2006070372 | Jul 2006 | WO |
2007084547 | Jul 2007 | WO |
2007144782 | Dec 2007 | WO |
2008008291 | Jan 2008 | WO |
2008035337 | Mar 2008 | WO |
2008042266 | Apr 2008 | WO |
2008047092 | Apr 2008 | WO |
2008047354 | Apr 2008 | WO |
2008053469 | May 2008 | WO |
2008107885 | Sep 2008 | WO |
2008140796 | Nov 2008 | WO |
2009078010 | Jun 2009 | WO |
2009116041 | Sep 2009 | WO |
2009116042 | Sep 2009 | WO |
2009118733 | Oct 2009 | WO |
2010024869 | Mar 2010 | WO |
2010024879 | Mar 2010 | WO |
2010031060 | Mar 2010 | WO |
2010045238 | Apr 2010 | WO |
2010062355 | Jun 2010 | WO |
2010088776 | Aug 2010 | WO |
2010128162 | Nov 2010 | WO |
2010150208 | Dec 2010 | WO |
2011004374 | Jan 2011 | WO |
2011007354 | Jan 2011 | WO |
2011055364 | May 2011 | WO |
2011064782 | Jun 2011 | WO |
2011067764 | Jun 2011 | WO |
2011070576 | Jun 2011 | WO |
2011080738 | Jul 2011 | WO |
2011095979 | Aug 2011 | WO |
2011106532 | Sep 2011 | WO |
2011106533 | Sep 2011 | WO |
2011106544 | Sep 2011 | WO |
2012049679 | Apr 2012 | WO |
2012104842 | Aug 2012 | WO |
2012111006 | Aug 2012 | WO |
2012117395 | Sep 2012 | WO |
Entry |
---|
“E-vita® open plus” product brochure (JOTEC GmbH, Hechingen, Germany) (2010). |
An English Translation of an Office Action dated Aug. 25, 2011, which issued during the prosecution of Chinese Patent Application No. 200880014919.9. |
Fonseca A et al., “Intravascular ultrasound assessment of the novel AngioSculpt scoring balloon catheter for the treatment of complex coronary lesions,” J Invasive Cardiol 20(1):21-7 (Jan. 2008). |
An International Search Report and a Written Opinion both dated Sep. 24, 2012, which issued during the prosecution of Applicant's PCT/IL2012/000060. |
Khlif H et al., “Contribution to the Improvement of Textile Vascular Prostheses Crimping,” Trends in Applied Sciences Research 6(9):1019-1027 (2011). |
An International Search Report and a Written Opinion both dated Jul. 13, 2012, which issued during the prosecution of Applicant's PCT/IL2012/000083. |
An International Search Report and a Written Opinion both dated Jul. 17, 2012, which issued during the prosecution of Applicant's PCT/IL2012/000095. |
An International Search Report and a Written Opinion both dated Aug. 31, 2012, which issued during the prosecution of Applicant's PCT/IL2012/000148. |
An International Search Report and a Written Opinion both dated Sep. 6, 2012, which issued during the prosecution of Applicant's PCT/IL2012/000190. |
An International Search Report and a Written Opinion both dated Jun. 19, 2012, which issued during the prosecution of Applicant's PCT/IL2012/000241. |
An International Search Report and a Written Opinion both dated Nov. 27, 2012, which issued during the prosecution of Applicant's PCT/IL2012/000300. |
An International Search Report and a Written Opinion both dated Feb. 4, 2011, which issued during the prosecution of Applicant's PCT/IB2010/052861. |
An International Search Report and a Written Opinion both dated Sep. 29, 2008, which issued during the prosecution of Applicant's PCT/IL08/000287. |
An International Search Report and a Written Opinion both dated Mar. 11, 2009, which issued during the prosecution of Applicant's PCT/IL2007/001312. |
An International Search Report and a Written Opinion both dated Jun. 30, 2009, which issued during the prosecution of Applicant's PCT/IL2008/001621. |
An International Search Report and a Written Opinion both dated Nov. 5, 2010, which issued during the prosecution of Applicant's PCTIL2010000549. |
An International Search Report and a Written Opinion both dated Dec. 3, 2010, which issued during the prosecution of Applicant's PCT/IL2010/000564. |
An International Search Report and a Written Opinion both dated Mar. 10, 2011, which issued during the prosecution of Applicant's PCT/IL2010/000917. |
An International Search Report and a Written Opinion both dated Aug. 4, 2011, which issued during the prosecution of Applicant's PCT/IL2010/000999. |
An International Search Report and a Written Opinion both dated Mar. 30, 2011, which issued during the prosecution of Applicant's PCT/IL2010/001018. |
An International Search Report and a Written Opinion both dated Apr. 18, 2011, which issued during the prosecution of Applicant's PCT/IL2010/001037. |
An International Search Report and a Written Opinion both dated May 23, 2011, which issued during the prosecution of Applicant's PCT/IL2010/001087. |
An International Search Report and a Written Opinion both dated Jun. 28, 2011, which issued during the prosecution of Applicant's PCT/IL2011/000135. |
An International Search Report dated Oct. 4, 2012, which issued during the prosecution of Applicant's PCT/IL2012/000269. |
An Office Action dated Apr. 27, 2011, which issued during the prosecution of U.S. Appl. No. 12/447,684. |
An Office Action dated Nov. 12, 2010, which issued during the prosecution of U.S. Appl. No. 12/447,684. |
An Office Action dated Mar. 24, 2011, which issued during the prosecution of U.S. Appl. No. 12/529,936. |
An Office Action dated Oct. 28, 2011, which issued during the prosecution of U.S. Appl. No. 12/529,936. |
An Office Action dated Jun. 19, 2012, which issued during the prosecution of U.S. Appl. No. 12/808,037. |
An Office Action dated Oct. 11, 2012, which issued during the prosecution of U.S. Appl. No. 13/031,871. |
European Search Report issued Feb. 24, 2014 in European Patent Application No. 12803376.8. |
An Advisory Action dated Feb. 13, 2014, which issued during the prosecution of Applicant's U.S. Appl. No. 13/807,880. |
An Office Action dated Feb. 28, 2014, which issued during the prosecution of Applicant's U.S. Appl. No. 13/512,778. |
European Office Action issued Dec. 17, 2014 in European Patent Application No. 12803376.8. |
Number | Date | Country | |
---|---|---|---|
20130204343 A1 | Aug 2013 | US |
Number | Date | Country | |
---|---|---|---|
61499195 | Jun 2011 | US |